Finding New Treatments for Diabetes--How Many, How Fast... How Good?

N Engl J Med. 2007 Feb 1;356(5):437-40. doi: 10.1056/NEJMp068294.

Publication types

  • Historical Article

MeSH terms

  • Adenosine Deaminase Inhibitors*
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl Peptidase 4
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Drug Approval*
  • Glucagon-Like Peptide 1 / drug effects
  • Glucagon-Like Peptide 1 / metabolism
  • Glycoproteins / antagonists & inhibitors*
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Hypoglycemic Agents / history
  • Hypoglycemic Agents / therapeutic use*
  • Peptide Fragments / drug effects
  • Peptide Fragments / metabolism
  • Pyrazines / therapeutic use*
  • Sitagliptin Phosphate
  • Triazoles / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Adenosine Deaminase Inhibitors
  • Dipeptidyl-Peptidase IV Inhibitors
  • Glycoproteins
  • Hypoglycemic Agents
  • Peptide Fragments
  • Pyrazines
  • Triazoles
  • Glucagon-Like Peptide 1
  • DPP4 protein, human
  • Dipeptidyl Peptidase 4
  • glucagon-like peptide 1 (7-37)
  • Sitagliptin Phosphate